Vital Innovations Holdings Limited

As of December 31, 2025, Vital Innovations Holdings Limited has 850.00M shares outstanding.

These figures are as of December 31, 2025.

These figures are as of December 31, 2025. The EV/Sales ratio of 0.22 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Vital Innovations Holdings Limited trades at an EV/FCF ratio of 11.40, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2025, Vital Innovations Holdings Limited maintains a current ratio of 5.07, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.91, indicating elevated leverage, while an interest coverage ratio of -12.82 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, Vital Innovations Holdings Limited posted a negative return on equity (ROE) of -3.74, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.96, reflecting losses generated across the asset base. Inventory turnover of 342.42 indicates how many times Vital Innovations Holdings Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on April 27, 2026, Vital Innovations Holdings Limited's stock has gained approximately 39.90% over the past 52 weeks. The 50-day moving average sits at 0.24, while the 200-day moving average is 0.23.

Over the twelve months ended December 31, 2025, Vital Innovations Holdings Limited posted a gross margin of 0.53, reflecting its pricing power and cost economics. The operating margin of -2.54 and net profit margin of -2.64 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield reaches 13.21, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Vital Innovations Holdings Limited shareholders.

As of December 31, 2025, Vital Innovations Holdings Limited has an Altman Z-Score of 2.40, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.